Literature DB >> 12114794

Metastatic Psammomatous Somatostatinoma of the Pancreas Causing Severe Ketoacidotic Diabetes Cured by Surgery.

Fausto Sessa1, Massimo Arcidiaco, Luigi Valenti, Marco Solcia, Enrico Di Maggio, Enrico Solcia.   

Abstract

A case of somatostatin-producing pancreatic tumor associated with severe insulin-dependent diabetes mellitus and ketoacidotic coma is reported. The tumor, a 10-cm expansile mass arising from the pancreatic tail of a 70-yr-old woman, was first detected by ultrasonography, performed because of abdominal pain, and subsequently confirmed by computed tomography and fine-needle tumor aspiration. Pathologic investigation showed a predominantly solid-trabecular structure with scattered microacini and psammomatous bodies. A large proportion of tumor cells expressed somatostatin and/or calcitonin. Following resection of the primary tumor and three peripancreatic lymph nodes with metastases, the patient recovered rapidly from her diabetic syndrome and remained in substantially good health during a subsequent 8-yr follow-up period, without evidence of tumor recurrence.

Entities:  

Year:  1997        PMID: 12114794     DOI: 10.1007/bf02739935

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  17 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Malignant somatostatinoma: clinical features and metabolic studies.

Authors:  L Axelrod; M A Bush; H J Hirsch; S W Loo
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

Review 3.  Endocrine tumors of the pancreas.

Authors:  P Rossi; D J Allison; M Bezzi; A Kennedy; F Maccioni; D Wynick; A Maradei; S R Bloom
Journal:  Radiol Clin North Am       Date:  1989-01       Impact factor: 2.303

4.  Prognostic criteria in nonfunctioning pancreatic endocrine tumours.

Authors:  S La Rosa; F Sessa; C Capella; C Riva; B E Leone; C Klersy; G Rindi; E Solcia
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

5.  "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas.

Authors:  O P Ganda; G C Weir; J S Soeldner; M A Legg; W L Chick; Y C Patel; A M Ebeid; K H Gabbay; S Reichlin
Journal:  N Engl J Med       Date:  1977-04-28       Impact factor: 91.245

6.  Glucose turnover and gluconeogenesis in a patient with somatostatinoma.

Authors:  S F Lowry; M E Burt; M F Brennan
Journal:  Surgery       Date:  1981-03       Impact factor: 3.982

7.  Somatostatinoma syndrome. Biochemical, morphologic and clinical features.

Authors:  G J Krejs; L Orci; J M Conlon; M Ravazzola; G R Davis; P Raskin; S M Collins; D M McCarthy; D Baetens; A Rubenstein; T A Aldor; R H Unger
Journal:  N Engl J Med       Date:  1979-08-09       Impact factor: 91.245

8.  Psammomatous somatostatinomas of the duodenum.

Authors:  Y Dayal; W G Doos; M J O'Brien; G Nunnemacher; R A DeLellis; H J Wolfe
Journal:  Am J Surg Pathol       Date:  1983-10       Impact factor: 6.394

9.  Psammoma bodies in endocrine tumors of the gastroenteropancreatic axis: a rather common occurrence.

Authors:  M H Greider; K DeSchryver-Kecskemeti; F T Kraus
Journal:  Semin Diagn Pathol       Date:  1984-02       Impact factor: 3.464

Review 10.  Pancreatic somatostatinoma: a case report and review of the literature.

Authors:  K Konomi; K Chijiiwa; T Katsuta; K Yamaguchi
Journal:  J Surg Oncol       Date:  1990-04       Impact factor: 3.454

View more
  2 in total

Review 1.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

2.  Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Eleni Papoutsi; Vasiliki Ntella; Prodromos Kanavidis; Athanasios Sioulas; Marina Tsoli; Georgios Charalampopoulos; Michail Vailas; Evangelos Felekouras
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.